Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo.

Crawford ED, Wilson SS, McConnell JD, Slawin KM, Lieber MC, Smith JA, Meehan AG, Bautista OM, Noble WR, Kusek JW, Nyberg LM, Roehrborn CG, MTOPS RESEARCH Group. Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo. J Urol 2006 Apr;175(4):1422-6; discussion 1426-7.

PubMed ID: 16516013
Public Release Type: Journal
Publication Year: 2006
Affiliation: University of Colorado Health Sciences Center, Aurora, Colorado, USA. david.crawford@uchsc.edu
DOI: https://doi.org/10.1016/S0022-5347(05)00708-1
Authors: Kusek JW, Crawford ED, Wilson SS, McConnell JD, Slawin KM, Lieber MC, Smith JA, Meehan AG, Bautista OM, Noble WR, Nyberg LM, Roehrborn CG, MTOPS RESEARCH Group
Studies: Medical Therapy of Prostatic Symptoms

Abstract

We analyzed data from the placebo arm of the MTOPS trial to determine clinical predictors of BPH progression.

Home chevron_right Publications chevron_right Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo.

Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo.

Abstract